Molecure (1B1.F) traded down -4.85 % during a 24 hours period ending at 11:54 PM Central Europe on Monday 26th. One Molecure stock can currently be bought for about PLN 5.98 on popular exchanges. Current supply of Molecure stocks is 20.6 mn. Molecure has a current market capitalization of PLN 117.2 mn and approximately PLN 445 k worth of Molecure was traded on exchanges in the last 24 hours. Since last month end, Molecure has traded -21.19 % down. Simple moving average of last 200 days is at PLN 6.3. The highest price of past 52 weeks was recorded at PLN 9.04 on 01/28/2026. 52 weeks low was at PLN 4.98 on 03/30/2026.

Here is how related stocks have performed in the past 24 hours:

  • Ml System (6UX.F) traded down -0.14 % and now trades at PLN 14. Ml System has a market capitalisation of PLN 102 mn.

  • M4b (24D.F) traded up 6.67 % and now trades at PLN 16. Current market capitalisation for M4b is PLN 118.7 mn.

  • Bowim (Z39.F) traded up 0.59 % and now trades at PLN 7. Current market capitalisation for Bowim is PLN 115.9 mn. Current price/earnings ratio for Bowim is 5.55.

  • Pjpmakrum (E92.F) traded down -2.73 % and now trades at PLN 21.8. Current market capitalisation for Pjpmakrum is PLN 128 mn. Pjpmakrum has a current price to earnings ratio of 78.07.

  • Hipower Energy Saa (8G6.F) traded down -10.77 % and now trades at PLN 0.37. Hipower Energy Saa has a market capitalisation of PLN 111.8 mn.

About Molecure

Molecure SA is a biopharmaceutical company based in Warsaw, Poland, that specializes in the discovery, development, and commercialization of drugs for the treatment of neoplastic and inflammatory diseases. The company is actively developing several clinical candidates, including OATD-01 for the treatment of asthma, CHIT1 inhibitor for the treatment of idiopathic pulmonary fibrosis and sarcoidosis, YKL-40 for the treatment of glioblastoma multiforme and other types of cancers, and other drugs. OncoArendi Therapeutics S.A. was founded in 2012 and has its main office in Warsaw, Poland. You can find more information about the company and its initiatives on their website at www.oncoarendi.com , and they are also listed on the Warsaw Stock Exchange.